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Abstract The polylactosamine sLexß l -3 ' ( sLexß l -6 ' )Lac -
NAcßl -3 ' ( sLexß l -6 ' )LacNAcßl -3 ' ( sLexß l -6 ' )LacNAc (7) 
(where sLex is Neu5Aca2-3Galßl^t(Fucal-3)GlcNAc and 
LacNAc is Galßl^4GlcNAc) is a nanotnolar L-selectin antago-
nist and therefore a potential anti-inflammatory agent (Renko-
nen et al. (1997) Glycobiology, 7, 453). Here we describe an 
improved synthesis of 7. The octasaccharide L a c N A c ß l -
3'LacNAcßl-3'LacNAcßl-3'LacNAc (4) was converted into 
the triply branched undecasaccharide LacNAcßl-3' (GlcNAcßl-
6 ' )LacNAcßl-3 ' (GlcNAcßl-6 ' )LacNAcßl-3 ' (GlcNAcßl-6 ' ) -
LacNAc (5) by incubation with UDP-GlcNAc and the midchain 
ßl,6-GlcNAc transferase activity of rat serum. Glycan 5 was 
enzymatically ßl,4-galactosylated to LacNAcßl-3 ' (LacNAcßl-
6' )LacNAcßl-3' (LacNAcßl-6' )LacNAcßl-3' (LacNAcßl-6' ) -
LacNAc (6). Combined with the enzymatic conversion of 6 to 7 
(Renkonen et al., loe. cit.) and the available chemical synthesis of 
4, our data improve the availability of 7 for full assessment of its 
anti-inflammatory properties. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Lymphocyte extravasation to rejecting graft is initiated by 
interactions between L-selectin and saccharides that carry 
epitopes related to the tetrasaccharide Neu5Accc2-3Galßl -
4(Fucocl-3)GlcNAc, which is known as the sialyl Lewis x 
(sLex) determinant [1,2]. Inflammatory stimuli induce the ex-
pression of the sLex type saccharides on the surface of the 
endothelium [3] to attract L-selectin-expressing lymphocytes 
to the graft. We have shown previously that a triply branched 
poly-./V-acetyllactosamine, s L e x ß l - 3 ' ( s L e x ß l - 6 ' ) L a c N A c ß l -
3 ' ( sLexß l -6 ' )LacNAcßl -3 ' ( sLexß l -6 ' )LacNAc (7) (where 
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Abbreviations: Fue, L-fucose; Gal, D-galactose; GlcNAc, TV-acetyl-D-
glucosamine; HexN Ac, TV-acetyl-D-glucosamine or JV-acetyl-D-manno-
samine; HPAEC, high pH anion exchange chromatography; LacNAc, 
/v-acetyllactosamine or Galßl^GlcNAc; MALDI-TOF-MS, matrix-
assisted laser desorption/ionization mass spectrometry with time-of-
flight detection; MH, maltoheptaose; MP, maltopentaose; Neu5Ac, 
/V-acetyl-neuraminic acid; NMR, nuclear magnetic resonance; PAD, 
pulsed amperometric detection; sLex, sialyl Lewis x or Neu5Aca2-
3Galß l^(Fucal-3)GlcNAc 
LacNAc is the disaccharide Ga lß l^ lG lcNAc) , inhibits effi-
ciently lymphocyte adhesion to the endothelium in vitro 
[4,5]. The presence of exogenous glycan 7 at 1 n M was shown 
to reduce lymphocyte adhesion to the rejection-activated en-
dothelium in cardiac transplants by 50%, probably through 
competition for L-selectin with endothelial sLex saccharides. 
This property makes glycan 7 an interesting anti-inflamma-
tory drug candidate. 
Here, we describe a simplified and upscalable synthesis 
route to the L-selectin antagonist 7. In the key step of the 
new synthesis, the linear octasaccharide L a c N A c ß l - 3 ' L a c -
NAcß 1 - 3 ' L a c N A c ß 1-3 'LacNAc (4) was incubated with 
UDP-GlcNAc and the midchain ß l ,6-GlcNAc transferase ac-
tivity present in rat serum [6,7]. The product, L a c N A c ß l -
3 ' ( G l c N A c ß l - 6 ' ) L a c N A c ß l - 3 ' ( G l c N A c ß l - 6 ' ) L a c N A c ß l - 3 ' 
(G lcNAcß l -6 ' )LacNAc (5), was then enzymatically ßl,4-ga-
lactosylated to yield the tetradecasaccharide L a c N A c ß l -
3 ' ( L a c N A c ß l - 6 ' ) L a c N A c ß l - 3 ' ( L a c N A c ß l - 6 ' ) L a c N A c ß l - 3 ' 
(LacNAcß l -ö ' )LacNAc (6). To complete the novel synthesis 
of the L-selectin antagonist 7, glycan 6 is sialylated and fuco-
sylated as described already in our previous report [4]. 
2. Materials and methods 
2.1. Synthesis of the heptasaccharide 1 
Details of the synthesis and characterization of the heptasaccharide 
LacNAcßl-3'(Fucal-3)LacNAcßl-3'LacNAc (1) will be described 
elsewhere (Niemelä et al., in preparation). Briefly, GlcNAcß 1-3'Lac-
NAcß 1-3'LacNAc [8], was al,3-fucosylated partially by using al,3/4 
fucosyltransferase(s) of human milk [9]. The fraction of monofucosy-
lated products was isolated by paper chromatography and the hexa-
saccharide GlcNAcßl-3'(Fucal-3)LacNAcßl-3'LacNAc was iso-
lated from this fraction by WGA-agarose chromatography (Niemelä 
et al., loe. cit.) and converted to radiolabeled glycan 1 by enzymatic 
ß 1,4-galactosylation. 
The difucosylated glycan LacNAcßl-3'(Fucal-3)LacNAcßl-
3'(Fucal-3)LacNAc was obtained in an analogous fashion, starting 
from an exhaustively oel,3-fucosylated sample of GlcNAcßl-3'Lac-
NAcßl-3'LacNAc. 
2.2. Enzymatic methods 
The ßl,3-GlcNAc transferase (EC 2.4.1.149) reaction and the ßl,4-
Gal transferase (EC 2.4.1.90) reaction were carried out essentially as 
described in [10] and [11], respectively. The multiple midchain ßl,6-
GlcNAc transferase reaction was performed by incubating the accept-
or with UDP-GlcNAc and the ßl,6-GlcNAc transferase activity 
present in rat serum that was concentrated 4—5 fold by ultrafiltration 
[V]. 
2.3. Acid hydrolysis 
The fucose residue was removed from neutral polylactosamine 
backbones by mild acid hydrolysis as described by Renkonen et al. 
[12]. 
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Fig. 1. Outline of the present enzymatic synthesis of primer 4. The fucose residue in the midchain of the primer, heptasaccharide 1, was re-
quired to inhibit the branching reactions [18] that would have occurred in our system at the non-fucosylated acceptor because of the presence 
of a contaminating midchain ßl,6-GlcNAc transferase activity [7,8]. 
2.4. Chromatographie methods 
Descending paper chromatography was carried out as described [7] 
using n-butanol/acetic acid/water (10:3:7 v/v) as the solvent. 
Gel permeation chromatography was performed as in [4]. 
HPAE chromatography with either pulsed amperometric detection 
or liquid scintillation counting was carried out as described [7]. 
The oligosaccharide content of individually pooled peaks was esti-
mated by Superdex 75 HR 10/30 chromatography with UV-detection 
[4]. 
2.5. MALDI-TOF-MS 
MALDI-TOF mass spectrometry was performed as described [7]. 
Table 1 
'H-NMR chemical shifts of structural reporter groups of glycans 2, 3, 4, 5 and 6 at 23°C 
Reporter group Residue Glycan 
2 3 4 5 6 
H-l 
H-4 
H-6 
2 
3 
4 
5 
6 
7 
8 
9 
10,11 
12,13,14 
15 
2 
4 
6 
15 
5.204 (a) 
4.720 (ß) 
4.460 
4.712 
4.445 
4.696 
4.467 
4.680 
_ C 
5.115 
4.154 
4.098 
4.154 
1.151 
5.203 (a) 
n.d.a 
4.46 
4.712 
4.445 
4.695 
4.467 
4.700 
4.479 
5.115 
4.157 
4.098 
4.157 
1.151 
5.204 (a) 
4.720 (ß) 
4.465 
4.701/4.698b 
4.465 
4.701 
4.465 
4.701 
4.479 
-
4.156 
4.156 
4.156 
-
5.212 (a) 
4.730 (ß) 
4.456 
4.702/4.696 
4.456 
4.696 
4.456 
4.696 
4.479 
4.585 
4.593 
4.146 
4.146 
4.146 
5.210 (a) 
4.726 (ß) 
4.460 
4.701/4.697 
4.460 
4.697 
4.460 
4.697 
4.480 
4.625/4.619 
4.639 
4.464 
4.148 
4.148 
4.148 
Numbering of the residues is shown in Figs. 1 and 5. 
an.d., not determined. 
bThe two chemical shifts given arise from signals representing the two anomeric forms of the glycan. 
c-, not appropriate. 
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2.6. 'H-NMR spectroscopy 
'H-NMR spectroscopy was performed as described by Maaheimo 
et al. [13]. 
3. Results 
3.1. Enzyme-assisted synthesis of the linear octasaccharide 
primer LacNAcßl-3'LacNAcßl-3'LacNAcßl-3'LacNAc 
(4) 
Glycan 4, which is involved in the key step in the present 
synthesis of glycan 7, has been synthesized chemically [14,15]. 
We synthesized it enzymatically. For this, the heptasaccharide 
LacNAcßl-3'(Fucal-3)LacNAcßl-3'LacNAc (1) was first 
elongated by the ßl,3-GlcNAc transferase activity of human 
serum [16,17]. The fucosylated derivative of LacNAcßl-
3'LacNAcß 1-3'LacNAc was used as acceptor instead of the 
fucose-free hexasaccharide itself because the fucosyl residue 
prevents the action of the midchain ßl,6-GlcNAc transferase 
activity of serum [18], which catalyzes the formation of 
GlcNAc-branches at the inner galactose residues of the hex-
asaccharide. 
The resulting glycan 2 (see Fig. 1 for the structure) was 
purified by gel filtration, followed by HPAE-chromatography 
(not shown), and in some experiments by paper chromatog-
raphy (AMP = 0.74, 7?MH = 1.10). In three separate experiments, 
the actual yields of purified glycan 2 averaged 33%. The 
MALDI-TOF mass spectrum (not shown) confirmed that 
the product had the molecular mass of Gal3GlcNAc4Fuc; a 
major peak assigned to (M+Na)+ was observed at mlz 1485.4 
(cale, miz 1485.5) and an accompanying signal, assigned to 
(M+K)+ was seen at mlz 1501.4 (cale, miz 1501.6). An 'im-
purity peak' (16%) of the spectrum at mlz 1282.4 was assigned 
to (M+Na)+ of Gal3HexNAc3Fuc. As this spectrum was ob-
tained from a HPAE-chromatographically purified sample, 
this species may represent a reducing-end ManNAc epimer 
of the acceptor saccharide (1) [19]. Prompt fragmentation of 
HexNAc units has not been observed with this type of glycans 
in the MALDI-TOF system used. The 'H-NMR spectrum 
confirmed the structure of 2 (Table 1). As expected, no reso-
nances were observed around 4.58^.59 ppm, in the area of 
the reported H-l signals of ßl,6-bonded GlcNAc residues of 
polylactosamines [7,20,21]. The successful terminal ßl,3-iV-
acetylglucosaminylation of glycan 1 at its LacNAcßl-
3'(Fucod-3)LacNAc determinant in the present experiments 
is sharply contrasted by the unreactivity of Fucocl-3LacNAc 
with the serum ßl,3-GlcNAc transferase [16]. 
Glycan 2 was ßl,4-galactosylated to give glycan 3. The 
product was purified by gel filtration and in some experiments 
by paper chromatography (AMP =0.53, Í?MH = 0 .78) . The 
yields of the purified product in two experiments averaged 
66%. MALDI-TOF-MS of Gal4GlcNAc4Fuc (not shown) 
had an abundant peak appropriate for the (M+Na)+ at mlz 
\6A1.6 (cale, miz 1647.6) and a low abundance (M+K)+ at mlz 
1663.4 (cale, miz 1663.7). The !H-NMR spectrum of glycan 3 
(Table 1) confirmed the structure shown in Fig. 1. 
Glycan 3 was converted into glycan 4 by removing the 
Fig. 2. MALDI-TOF mass spectrum of (A) the primer glycan 4, (B) 
the triply branched glycan 5 and (C) the galactosylated glycan 6. 
The minor signal in panel C, observed at mlz 2232.9, was assigned 
to (M+Na)+ of Gal6HexNAc6 (cale, miz for Gal6HexNAc6 2233.0). 
This impurity could have been formed from a small amount of 
GaLiHexNAce in the acceptor glycan which was observed in the 
MALDI-TOF mass spectrum of 5. 
fucose residue by mild acid hydrolysis; the product was puri-
fied by gel filtration using two consecutive Superdex 75 HR 
10/30 columns. The yields of purified 4 in two experiments 
averaged 44%. MALDI-TOF-MS confirmed that the product 
was essentially fucose-free. The spectrum showed a major 
peak at mlz 1502.3, and an accompanying signal at mlz 
1518.3 (Fig. 2A); these were assigned to (M+Na)+ and 
(M+K)+, respectively, of Gal4GlcNAc4 (cale, miz 1502.3 
and 1518.4, respectively). The 'H-NMR spectrum also con-
firmed the postulated structure of glycan 4 (Table 1, Fig. 3A). 
Overall, the structural reporter group region of glycan 4 re-
sembled closely that obtained from the linear hexasaccharide 
LacNAcß 1-3'LacNAcß 1-3'LacNAc [7]. 
Glycan 4 was succesfully synthesized also from the difuco-
sylated glycan LacNAcßl-3'(Fucocl-3)LacNAcßl-3'(Fuccel-
3)LacNAc in experiments analogous to those described above. 
Radiolabeled glycan 4 was obtained by using UDP-[14C]Gal 
in the final ßl,4-galactosylation reaction. 
Fig. 3. Anomeric regions of 'H-NMR spectra of (A) the primer glycan 4, (B) the triply branched glycan 5 and (C) the galactosylated glycan 6 
of the present synthesis route. For numbering of the monosaccharide residues, see Fig. 5. 
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3.2. Enzyme-assisted conversion of glycan 4 into the triply 
branched undecasaccharide LacNAcßl-3' (GlcNAcßl-6')-
LacNAcßl-3' (GlcNAcßl-6' )LacNAcßl-3' (GlcNAcßl-
6')LacNAc (5) 
Incubation of the enzymatically synthesized glycan 4 (40.3 
nmol) with UDP-GlcNAc and the midchain ßl,6-GlcNAc 
transferase activity present in rat serum [6,7], gave several 
products that were separated by HPAE chromatography 
(Fig. 4). MALDI-TOF mass spectrum of the principal prod-
uct (peak 7 in Fig. 4) showed a major signal at mlz 2111.9 that 
was assigned to (M+Na)+ of Gal4GlcNAc7 (calculated mlz 
2111.9) (Fig. 2B); an accompanying signal at mlz 2128.0 
was assigned to the corresponding (M+K)+ (calculated mlz 
2128.0). Hence, the major product of the branching reaction 
was an undecasaccharide that contained three newly trans-
ferred GlcNAc residues. The 'H-NMR spectrum of the prin-
cipal product (Fig. 3B; Table 1) revealed the presence of three 
new protons resonating at 4.585-4.593 ppm, in the area char-
acteristic to Hi 's of ßl,6-bonded GlcNAc-residues. The re-
porter group signals originating from the main chain of the 
product resembled very closely their counterparts found in the 
spectra of the branched pentasaccharide LacNAcß 1-
3'(GlcNAcßl-6')LacNAc [13,21] and the doubly branched 
octasaccharide LacNAcß 1-3' (GlcNAcß 1 -6 ')LacNAcß 1-
3'(GlcNAcßl-6')LacNAc [7]. These data establish the struc-
ture of the undecasaccharide product as LacNAcßl-
3'(GlcNAcßl-6')LacNAcßl-3'(GlcNAcßl-6')LacNAcßl-3'(-
GlcNAcßl-6')LacNAc (5). The yield of glycan 5 was 10.6 
nmol (26%). Another branching experiment with UDP-
GlcNAc and concentrated rat serum was performed with a 
3 nmol/25 800 cpm-sample of 14C-labeled glycan 4. The radio-
activity profile (not shown) resulting from HPAE chromatog-
raphy was remarkably similar to the PAD-profile of Fig. 4. 
The analog of peak 7/Fig. 4 contained 6000 cpm of glycan 5 
(23% yield) that showed in MALDI-TOF-MS the same sig-
nals as peak 7 of Fig. 4. 
The numerous side-products in Fig. 4 were analyzed by 
MALDI-TOF-MS (not shown). Peak 2 represented fucosyl-
ated glycans and peak 3 the unreacted glycan 4. The singly 
branched glycans appeared in peak 4, while peaks 5 and 6 
probably represented doubly branched products and peak 8 
their ManNAc epimers. Peak 9 represented a triply branched 
product GaUHexNAc7, most likely the reducing-end Man-
0.0 ■ 
8.0 
6.0 ■ 
4.0 
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GlcNAcplv. '■ 
GlcNAcßlN. §r .acNAc[ i l ' ' J 
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, 
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^^~~ 
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3 * 5,. ii J\ 
--'" 
Fig. 4. HPAE chromatography of the oligosaccharides resulting 
from the incubation of glycan 4 with UDP-GlcNAc and concen-
trated rat serum. Peak 3 consists of glycan 4 while peak 7 represents 
glycan 5 and peak 1 is internal lactose marker. MALDI-TOF-MS 
experiments suggested that peaks 4-9 represent derivatives of the 
primer and/or its reducing-end ManNAc epimer containing one, two 
or three ßl,6-bonded GlcNAc branches. The large number of peaks 
probably reflects also partial separation of branch isomers [7]. 
NAc epimer of glycan 5. Peaks 3-6 gave also signals of ions 
missing one galactose. Taken together, the data suggest that 
improvements in the yield of glycan 5/peak 7 will be possible 
if (i) the branching reaction can be forced closer to completion 
and (ii) a purification method can be used that exposes the 
glycans to less basic conditions than those prevailing in HPAE 
chromatography, which catalyses partial epimerization at the 
unprotected reducing-end [19]. 
3.3. Enzyme-assisted synthesis of the tetradecasaccharide Lac-
NAcßl-3'(LacNAcßl-6')LacNAcßl-3'(LacNAcßl-6' ) -
LacNAcßl-3' (LacNAcßl-6'JLacNAc (6) 
Enzymatic ßl,4-galactosylation of glycan 5 gave a major 
product, glycan 6, with the yield of 85%. MALDI-TOF-MS 
of the product (Fig. 2C) showed a major peak at mlz 2598.2 
that was assigned to (M+Na)+ of Gal7GlcNAc7 (cale, miz 
2598.3); an accompanying signal assigned to (M+K)+ of 
Gal7GlcNAc7 was seen at mlz 2614.3 (cale, miz 2614.4). The 
structure of glycan 6 was confirmed by 'H-NMR spectros-
copy (Fig. 3C). The 4.464-ppm signals assigned to Hi 's of 
the newly transferred branch galactoses 12, 13 and 14 in the 
tetradecasaccharide 6 were identical to the analogous signals 
in the decasaccharide LacNAcßl-3'(LacNAcßl-6')Lac-
NAcßl-3'(LacNAcßl-6')LacNAc [7] and the hexasaccharide 
LacNAcßl-3'(LacNAcßl-6')LacNAc [22]. Glycan 6, synthe-
sized enzymatically via another route in our previous experi-
ments [4], gave a proton NMR-spectrum (not shown) that was 
identical with that of Fig. 3C. 
4. Discussion 
The present data represent distinct improvements in the 
enzyme-assisted synthesis of glycan 7 (for the structural for-
mula see Fig. 5), a tetravalent sialyl Lewis x (sLex) glycan that 
is a nanomolar inhibitor of L-selectin-mediated adhesion of 
lymphocytes to the inflammation-activated endothelium of re-
jecting cardiac transplants of rats [4]. The increased availabil-
ity of glycan 7, in turn, will lead to better assessment of the 
anti-inflammatory potential of this oligosaccharide in different 
in vivo inflammation models using experimental animals. The 
putative roles of glycan 7 and related saccharides as potential 
antagonists of E- and P-selectins will also merit a study when 
these glycans become available in sufficient amounts. 
The major improvement in the synthesis of glycan 7 consists 
of the use of the octasaccharide LacNAcßl-3LacNAcßl-
3 LacNAcß 1-3 LacNAc (4) rather than the hexasaccharide 
LacNAcßl-3LacNAcßl-3LacNAc as the primer, and four 
rather than six enzymatic steps to convert the primer into 
the tetravalent sLex-saccharide sLexßl-3'(sLexßl-6')Lac-
NAcßl-3'(sLexßl-6')LacNAcßl-3'(sLexßl-6')LacNAc (7) 
as shown in Fig. 5. The key reaction in the novel synthesis 
is the conversion of the linear octasaccharide 4 into the triply 
branched undecasaccharide 5 in a single-step transformation 
catalyzed by the midchain ßl,6-GlcNAc transferase activity of 
rat serum. In the future this reaction will be catalyzed by the 
recombinant form of the midchain ßl,6-GlcNAc transferase 
of embryonal carcinoma cells, which we have recently ex-
pressed in báculo virus-infected Spodoptera frugiperda (Sf9) in-
sect cells and isolated in an active form (P. Mattila et al., in 
preparation). Another major advantage of the octasaccharide 
4 is that this glycan is accessible in considerable amounts by 
chemical synthesis in solution [14,15]. It appears probable that 
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Fig. 5. The present, improved synthesis route to the tetravalent sialyl Lewis x glycan 7. 
also solid phase chemical synthesis of glycan 4 will soon be-
come possible [23]. Its enzymatic synthesis, too, will probably 
develop rapidly when recombinant forms of the ßl,3-GlcNAc 
transferase become available. 
The triply branched undecasaccharide 5 was readily galac-
tosylated by ßl,4-galactosyl transferase of bovine milk, yield-
ing the branched array of seven iV-acetyllactosamine units 
that is shown as glycan 6 in Fig. 5. Glycan 6 of the present 
experiments was identical with a sample constructed in our 
early experiments via another route [4]; both samples revealed 
similar molecular weights in MALDI-TOF-MS and gave very 
similar ID 'H-NMR spectra, confirming the postulated struc-
ture of this oligosaccharide. Chemical synthesis of glycan 6 
has not been described yet, but related syntheses have been 
presented [24,25], suggesting that in the future glycan 6 will be 
accessible also by chemical synthesis. 
The enzymatic conversion of glycan 6 to the tetravalent 
sLex glycan 7 has been described before [4]; no improvements 
are described in the present report to the two reactions in-
volved. 
It remains to be seen whether chemical, enzymatic or hybrid-
ized chemo-enzymatic approaches will prove to be the most 
efficient ones in providing branched poly-A^-acetyllactosamine 
backbones for construction of multivalent sLex saccharides 
and related glycans. 
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